Last updated: April 25, 2026
Who supplies potassium citrate at scale?
Potassium citrate is supplied through three primary channels: (1) commodity chemical producers (bulk API/intermediates), (2) excipient-grade and pharmaceutical-grade producers (tablet and effervescent markets), and (3) distributors that carry multi-grade inventories and support regulatory documentation.
Market segmentation by grade (how suppliers typically position)
| Grade used in practice |
Typical buyer |
Examples of supplier types |
| Food/animal (lower purity targets) |
Beverage, food additive |
Commodity chemical firms and regional distributors |
| USP/NF or pharmacopeial (higher purity; specs managed) |
Pharmaceutical manufacturers |
Pharma-grade chemical producers and excipient specialists |
| EP/BP-aligned (and “technical” variants) |
EU-oriented buyers |
Regional European chemical producers and distributors |
| Injection or ultra-high purity claims (limited segment) |
Specialized dosage forms |
Small set of higher-compliance suppliers |
Which supplier categories matter to pharmaceutical procurement?
Pharma buyers usually select potassium citrate supply based on documentation, traceability, and compliance rather than only price.
Typical procurement requirements that narrow supplier lists
| Requirement |
What it filters for |
| GMP manufacturing statement (and often DMF/ASMF availability) |
Limits to pharma-grade manufacturers |
| CoA per batch with controlled impurities |
Eliminates many commodity-only sources |
| Microbial/bioburden specs (as applicable to excipient use) |
Narrows to excipient-grade capable producers |
| Particle size or effervescence-relevant specs |
Narrows to “direct to tablet” suppliers |
| Packaging validation (e.g., multi-layer bags; drum liners) |
Filters logistics and material-handling capabilities |
Which companies supply potassium citrate for pharmaceutical use?
The list below covers the major supplier and distribution landscape that repeatedly appears in pharma procurement workflows for potassium citrate (bulk and excipient grade). It is organized into (A) direct manufacturers and (B) distributors that provide regulatory-ready product documentation.
Direct manufacturers of potassium citrate (bulk/pharma grade)
Core global producers and excipient-grade suppliers
| Company |
Common sourcing route |
Market role |
| Merck KGaA (MilliporeSigma) |
Distributor-anchored procurement (often via lab and pharma channels) |
Global chemical supply with pharmacopeial cataloging |
| TCI Chemicals |
Direct catalog supply and pharma-grade variants |
High-availability chemical producer and trader |
| Hangzhou Dayangchem Co., Ltd. |
Bulk chemical supply for downstream buyers |
Bulk manufacturing and export orientation |
| Anhui Kingsway Chemicals Co., Ltd. |
Bulk export and industrial-to-pharma grade transitions |
Scale producer for salts and citrate families |
| Zhejiang Wyncer Chemical Co., Ltd. |
Bulk chemical export |
Large-scale salt producer |
| Hubei Sun Shine Pharmaceutical Co., Ltd. |
Pharma-oriented salt/supply channel |
Regional pharma-aligned chemical manufacturer |
Distributors that carry potassium citrate with pharma documentation
| Distributor |
Sourcing value to pharma buyers |
Where they fit |
| Univar Solutions |
Multi-grade inventory and documentation handling |
Excipient sourcing and bundling |
| Fisher Scientific (Thermo Fisher) |
Regulatory documentation and standardized CoA flows |
Lab-to-plant transitioning |
| VWR (Avantor) |
Broad SKU coverage and compliance documentation |
EU and global procurement support |
| SFS Enterprises / J. T. Baker channel providers |
Catalog availability and batch documentation |
Routine reorders and spot fills |
| Brenntag |
Broad chemical portfolio, compliance services |
Industrial-to-pharma grade sourcing |
| AkzoNobel industrial chemical distributors (regional coverage varies) |
Regional availability and logistics |
Local procurement with documentation |
Which sourcing paths reduce compliance risk?
Best-practice sourcing route map
- Direct manufacturer with GMP statement and pharmacopeial compliance
- Best for long-term supply, consistent specs, and validation packages.
- Authorized distributor with consistent CoA format
- Best for short lead times and stable reorder cycles.
- Tendering across at least two qualified suppliers
- Best for continuity if specs tighten or impurity profiles shift.
How to screen suppliers for potassium citrate quickly
Procurement teams typically reduce cycle time by using a spec-based checklist.
Supplier qualification checklist (pharma-facing)
- Pharmacopeial designation: USP, NF, EP, BP (as required by the formulation plan).
- Impurity profile controls: common citrate-salt impurities and related ion limits.
- Assay and moisture range: stable effervescence and dissolution performance depends on spec.
- Microbiological limits: relevant when used as an excipient in oral dosage forms.
- Packaging and labeling: lot traceability, tamper-evident options.
- CoA and SDS availability: both in standardized formats and same-lot alignment.
Regulatory and documentation considerations that affect supplier choice
Potassium citrate used in pharmaceuticals often maps to an excipient or API-like salt specification depending on product role.
Typical documentation deliverables that drive selection
| Document |
Why it matters |
| CoA (batch-specific) |
Confirms assay and impurities for each lot |
| SDS |
Required for EHS onboarding and storage controls |
| GMP statement or manufacturing compliance letters |
Required by QA for vendor qualification |
| Traceability evidence |
Supports audits and discrepancy investigations |
| Change control commitments |
Reduces risk of performance drift |
Reference specs buyers often align to
Procurement teams usually align incoming control specs to the target pharmacopeia for potassium citrate.
Common alignment points (by pharmacopeia)
| Spec category |
What buyers verify |
| Identity |
Confirmed by standard tests (e.g., citrate salt identity methods) |
| Assay |
Potassium citrate content range |
| Limit tests |
Insolubles, related substances, sulfate/chloride-type limits depending on pharmacopeia |
| Water content |
Critical for effervescence stability and handling |
| Microbial limits |
When relevant for excipients and oral formulations |
Lead times and volume: where supply concentration shows up
Potassium citrate is widely produced, but procurement bottlenecks usually come from:
- Pharma-grade inventory availability (not every producer holds pharmacopeial compliance stock continuously).
- Batch-to-batch impurity profile stability (tight pharmacopeial limits reduce “free switching” among suppliers).
- Packaging format constraints (drums vs bags; moisture-protective liners).
Pricing and contract structure signals that distinguish suppliers
Because potassium citrate is a commodity relative to complex APIs, contract structure matters more than marketing.
Supplier contracting patterns observed in market practice
| Contract lever |
What it changes |
| Incoterms (FOB/CIF/DDP) |
Delivered cost and lead time reliability |
| Packaging options |
Breaks pricing bands (bulk bag vs drum vs lined bag) |
| Spec-driven pricing tiers |
Pharmacopeial vs technical grade spreads |
| Annual supply agreements |
Often reduce volatility for validated lots |
| Change-notice lead times |
Required when impurity or supplier site changes |
Key Takeaways
- Potassium citrate sourcing typically splits between commodity chemical producers and pharmacopeial/excipient-grade supply, with compliance documentation as the differentiator.
- For pharmaceutical use, prioritize suppliers that provide pharmacopeial alignment (USP/NF and/or EP/BP), batch CoA consistency, and GMP or compliance statements.
- Vendor qualification is usually won by documentation completeness, impurity-control stability, and packaging traceability, not just unit price.
- Distributors can speed procurement, but long-term risk control favors direct manufacturers or distributors with stable pharma-grade inventory programs.
FAQs
-
Is potassium citrate sourced as an API or excipient depending on the drug product?
It can function as an excipient (salt/buffering agent) in oral formulations, and buyers often align controls to the relevant pharmacopeial standard for that intended use.
-
What documentation do pharma buyers typically require for potassium citrate?
Batch CoA, SDS, and GMP/manufacturing compliance statements aligned to the buyer’s quality system and pharmacopeial targets.
-
Do all suppliers offer USP/NF or EP-compliant potassium citrate?
No. Many producers manufacture commodity-grade citrate salts; pharmacopeial compliance is a narrower, spec-locked segment.
-
How do packaging and moisture protection affect potassium citrate supply?
Packaging format and liner choices influence moisture uptake and handling stability, which can affect dissolution behavior and specification pass rates.
-
What is the fastest way to add a second source for potassium citrate?
Qualify an alternative supplier already carrying the same pharmacopeial-grade designation and packaging format, using a document-first vendor onboarding to shorten audit cycles.
References
[1] Merck KGaA. MilliporeSigma. Potassium citrate product listing and specifications (catalog data).
[2] TCI Chemicals. Potassium citrate product listings and grade descriptions (catalog data).
[3] Univar Solutions. Chemical product catalog coverage for potassium citrate (distribution listings).
[4] Fisher Scientific. Potassium citrate product listing and documentation availability (catalog data).
[5] VWR (Avantor). Potassium citrate product listings (catalog data).
